(Q37857851)

24 August 2017

1 reference

title

Opportunities and challenges of the pulmonary route for vaccination (English)

1 reference

24 August 2017

Fabian Blank

1

0 references

author name string

Philip Stumbles

series ordinal

2

1 reference

24 August 2017

Christophe von Garnier

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

26 March 2011

1 reference

Expert Opinion on Drug Delivery

24 August 2017

published in

1 reference

24 August 2017

volume

8

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

547-563

1 reference

Pulmonary surfactant: an immunological perspective

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Innate immunity in the lung: how epithelial cells fight against respiratory pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Regulation of immunological homeostasis in the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

The alveolar macrophage: the forgotten cell in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Characterization of dendritic cell populations in the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Pulmonary dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Airway dendritic cells: co-ordinators of immunological homeostasis and immunity in the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Dendritic cells as vectors for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

CD4+ T cell-independent vaccination against Pneumocystis carinii in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Nanomedicine in pulmonary delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Dendritic cell-nerve clusters are sites of T cell proliferation in allergic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Diverse and potent chemokine production by lung CD11bhigh dendritic cells in homeostasis and in allergic lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Development and functional specialization of CD103+ dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Identification and characterization of human pulmonary dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Plasmacytoid dendritic cells migrate in afferent skin lymph

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae-induced Th2 inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Plasmacytoid dendritic cells control lung inflammation and monocyte recruitment in indirect acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

The pulmonary-alveolar macrophage (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Alveolar macrophages transport pathogens to lung draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Alveolar macrophages, surfactant lipids, and surfactant protein B regulate the induction of immune responses via the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Macrophages induce an allergen-specific and long-term suppression in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Alternative activation of macrophages: an immunologic functional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Macrophages: regulators of sex differences in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Deficiency of regulatory B cells increases allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Role of autophagy in innate viral recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Found in translation: the human equivalent of mouse CD8+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Danger signals: SOS to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

The impact of successive infections on the lung microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Antigen presentation to naive CD4 T cells in the lymph node.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

A powder formulation of measles vaccine for aerosol delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

A meta-analysis of studies comparing the respiratory route with the subcutaneous route of measles vaccine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Flu myths: dispelling the myths associated with live attenuated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Live attenuated vaccines against influenza; an historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Prospects for immunisation against Marburg and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

A novel and effective intranasal immunization strategy for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Is intranasal vaccination a feasible solution for tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Inhaling medicines: delivering drugs to the body through the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Nanoparticles and microparticles as vaccine-delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Rapid translocation of nanoparticles from the lung airspaces to the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Trojan particles: large porous carriers of nanoparticles for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Role of dendritic cells in the lung: in vitro models, animal models and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.565326

10.1517/17425247.2011.565326

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference